Stephen Harrison

基本信息

Career Trajectory

Bio

Practicing Since: 1995
Certifications/Publications: Board certified in Internal Medicine and Gastroenterology. Published more than 300 papers in liver disease.

Provider Quote: My goal and purpose as a Hepatologist is to ensure we have impactful treatments for patients suffering from liver disease to include Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis.

Research Interests

Papers共 929 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

ALADDIN: A Machine Learning Approach to Enhance the Prediction of Significant Fibrosis or Higher in Metabolic Dysfunction-Associated Steatotic Liver Disease

Naim Alkhouri, Terry Cheuk-Fung Yip,Laurent Castera, Marina Takawy,Leon A Adams,Nipun Verma,Juan Pablo Arab,Syed-Mohammed Jafri,Bihui Zhong,Julie Dubourg,Vincent L Chen,Ashwani K Singal,Luis Antonio Díaz, Nicholas Dunn,Rida Nadeem,Vincent Wai-Sun Wong,Manal F Abdelmalek, Zhengyi Wang,Ajay Duseja, Yousef Almahanna, Haya A Omeish,Junzhao Ye,Stephen A Harrison, Jessica Cristiu,Marco Arrese, Sage Robert,Grace Lai-Hung Wong, Amani Bajunayd,Congxiang Shao, Matthew Kubina,Winston Dunn

The American journal of gastroenterology (2025)

Cited0Views0WOSBibtex

A Phase IIb Randomised-Controlled Trial of the FFAR1/FFAR4 Agonist Icosabutate in MASH

Stephen A Harrison,Naim Alkhouri, Grisell Ortiz-Lasanta,Madhavi Rudraraju,Dean Tai,Katy Wack,Amrik Shah, Robin Besuyen, Hilde H Steineger,David A Fraser,Arun J Sanyal, ICONA Study Investigators

Journal of hepatology (2025)

Cited0Views0WOSBibtex

Safety and Efficacy of Efruxifermin in Combination with a GLP-1 Receptor Agonist in Patients with NASH/MASH and Type 2 Diabetes in a Randomized Phase 2 Study

Stephen A. Harrison,Juan P. Frias,K. Jean Lucas,Gary Reiss,Guy Neff, Sureka Bollepalli, Yan Su,Doreen Chan,Erik J. Tillman, Ali Moulton,Brittany de Temple,Arian Zari,Reshma Shringarpure,Timothy Rolph,Andrew Cheng,Kitty Yale

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY（2025）

Cited2Views0WOSBibtex

Rencofilstat Treatment Improves Liver Function in MASH with Advanced Fibrosis As Quantified by HepQuant DuO

Stephen A Harrison,Patrick Mayo,Todd Hobbs,Caroline Zhao, Carlos Canizares, Robert Foster,Michael P McRae,Steve M Helmke,Gregory T Everson

Liver international official journal of the International Association for the Study of the Liverno. 3 (2025): e70036-e70036

Cited0Views0WOSBibtex

Agile 3+ and 4 Scores Accurately Predict Major Adverse Liver Outcomes, Liver Transplant, Progression of MELD Score, the Development of Hepatocellular Carcinoma, and Death in NAFLD

Emily Truong, Lynna Alnimer, Jeffrey A Gornbein,Ju Dong Yang,Naim Alkhouri,Stephen A Harrison,Mazen Noureddin

Digestive diseases and sciences (2025)

Cited0Views0WOSBibtex

SAT-214 Using Machine Learning Models to Predict Baseline Fibrosis Stage in Patients from Phase 3 Resmetirom Trials (MAESTRO-NAFLD and MAESTRO-NASH)

Jörn M. Schattenberg,Quentin M. Anstee,Stephen A. Harrison,Mazen Noureddin,Rebecca Taub,Dominic Labriola, Jan Priel, Krishna Padmanabhan

Journal of Hepatology (2024): S611

Cited0Views0Bibtex

Integrating Liver Endpoints in Clinical Trials of Cardiovascular and Kidney Disease

Faiez Zannad,Arun J. Sanyal,Javed Butler,Veronica Miller,Stephen A. Harrison

NATURE MEDICINEno. 9 (2024): 2423-2431

Cited0Views0WOSNATUREBibtex

Association Between Advanced Fibrosis and NASH-CRN Activity Score (NAS) Components: Combined Data from Multiple Therapeutic Trials Including More Than 10, 000 Patients

Stephen A. Harrison,Julie Dubourg,Mazen Noureddin,Naim Alkhouri,Joern M. Schattenberg,Sophie Jeannin,Vlad Ratziu,Michael Charlton

JOURNAL OF HEPATOLOGY (2024): S37-S37

Cited0Views0Bibtex

897-P: Insulin-Sensitizing Effects of Efruxifermin Improve Glycemic Control in Patients with MASH and Type 2 Diabetes

K J. LUCAS,STEPHEN A. HARRISON,DOREEN CHAN,ERIK J. TILLMAN, ALI MOULTON,BRITTANY DE TEMPLE,ARIAN ZARI,RESHMA SHRINGARPURE,TIMOTHY ROLPH,ANDREW CHENG,KITTY YALE

Diabetesno. Supplement_1 (2024)

Cited0Views0Bibtex

521 ALT, FIBROSCAN VCTE, AND FIBROSCAN CAP AS PREDICTIVE MARKERS OF RESMETIROM BIOPSY RESPONSE

Rohit Loomba,Jorn Schattenberg,Rebecca Taub,Dominic Labriola,Mazen Noureddin,Vlad Ratziu,Stephen A. Harrison

Gastroenterologyno. 5 (2024): S-1550

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

Visiting Professor

Papers共 929 篇Author StatisticsCo-AuthorSimilar Experts